Resveratrol improves learning and memory in normally aged mice through microRNA-CREB pathway

Biochemical and Biophysical Research Communications

Volumn 435, Issue 4, 2013, Pages 597-602

  Zhao, Yong Na ^a,b   Li, Wei Feng ^a,b   Li, Fei ^a,b   Zhang, Zhen ^a,b   Dai, Yun Dong ^a,b   Xu, Ai Li ^c   Qi, Cui ^a   Gao, Ji Min ^b   Gao, Jun ^a  

^a NANJING UNIVERSITY   (China)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Aging; BDNF; CREB; Learning and memory; Micro RNA; Resveratrol; Sirtuin

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MICRORNA; MICRORNA 124; MICRORNA 134; RESVERATROL; SIRTUIN 1; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ELECTROPHYSIOLOGY; CENTRAL NERVOUS SYSTEM DISEASE; COGNITION; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEAR; GENE EXPRESSION; HIPPOCAMPAL CA1 REGION; LEARNING; LOCOMOTION; LONG TERM MEMORY; LONG TERM POTENTIATION; MEMORY; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; TREATMENT DURATION; UPREGULATION;

AGING; ANIMALS; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; HIPPOCAMPUS; LEARNING; MEMORY; MICE; MICE, INBRED C57BL; MICRORNAS; SIGNAL TRANSDUCTION; STILBENES;

MUS; RICE STRIPE VIRUS; VITACEAE;

EID: 84878990866     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.05.025     Document Type: Article

References (41)

1. Cantuti-Castelvetri I., Shukitt-Hale B., Joseph J.A. Neurobehavioral aspects of antioxidants in aging. Int. J. Dev. Neurosci. 2000, 18:367-381.
2. Harman D. Free-radical theory of aging. Increasing the functional life span. Ann. NY Acad. Sci. 1994, 717:1-15.
3. Fariello R.G. Biochemical profile of vulnerable neurons in neurodegenerative disorders. Int. J. Tissue React. 1990, 12:179-181.
4. Halder J., Bhaduri A.N. Protective role of black tea against oxidative damage of human red blood cells. Biochem. Biophys. Res. Commun. 1998, 244:903-907.
5. Saiko P., Szakmary A., Jaeger W., Szekeres T. Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad?. Mutat. Res. 2008, 658:68-94.
6. Harikumar K.B., Aggarwal B.B. Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008, 7:1020-1035.
7. Baur J.A., Sinclair D.A. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 2006, 5:493-506.
8. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?. Eur. J. Endocrinol. 1998, 138:619-620.
9. Soleas G.J., Diamandis E.P., Goldberg D.M. Resveratrol: a molecule whose time has come? And gone?. Clin. Biochem. 1997, 30:91-113.
10. Kim D., Nguyen M.D., Dobbin M.M., Fischer A., Sananbenesi F., Rodgers J.T., Delalle I., Baur J.A., Sui G., Armour S.M., Puigserver P., Sinclair D.A., Tsai L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 2007, 26:3169-3179.
11. Das M., Das D.K. Resveratrol and cardiovascular health. Mol. Aspects Med. 2010, 31:503-512.
12. Sakata Y., Zhuang H., Kwansa H., Koehler R.C., Dore S. Resveratrol protects against experimental stroke: putative neuroprotective role of heme oxygenase 1. Exp. Neurol. 2010, 224:325-329.
13. Dal-Pan A., Terrien J., Pifferi F., Botalla R., Hardy I., Marchal J., Zahariev A., Chery I., Zizzari P., Perret M., Picq J.L., Epelbaum J., Blanc S., Aujard F. Caloric restriction or resveratrol supplementation and ageing in a non-human primate: first-year outcome of the RESTRIKAL study in Microcebus murinus. Age (Dordr) 2011, 33:15-31.
14. Jang M., Cai L., Udeani G.O., Slowing K.V., Thomas C.F., Beecher C.W., Fong H.H., Farnsworth N.R., Kinghorn A.D., Mehta R.G., Moon R.C., Pezzuto J.M. Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 1997, 275:218-220.
15. Raval A.P., Dave K.R., Perez-Pinzon M.A. Resveratrol mimics ischemic preconditioning in the brain. J. Cereb. Blood Flow Metab. 2006, 26:1141-1147.
16. Yousuf S., Atif F., Ahmad M., Hoda N., Ishrat T., Khan B., Islam F. Resveratrol exerts its neuroprotective effect by modulating mitochondrial dysfunctions and associated cell death during cerebral ischemia. Brain Res. 2009, 1250:242-253.
17. Shin J.A., Lee H., Lim Y.K., Koh Y., Choi J.H., Park E.M. Therapeutic effects of resveratrol during acute periods following experimental ischemic stroke. J. Neuroimmunol. 2010, 227:93-100.
18. Zhang F., Wu Y. Resveratrol may be an effective prophylactic agent for ischemic stroke. J. Formos. Med. Assoc. 2011, 110:485-486.
19. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., Zipkin R.E., Chung P., Kisielewski A., Zhang L.L., Scherer B., Sinclair D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
20. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430:686-689.
21. Renthal W., Kumar A., Xiao G., Wilkinson M., Covington H.E., Maze I., Sikder D., Robison A.J., LaPlant Q., Dietz D.M., Russo S.J., Vialou V., Chakravarty S., Kodadek T.J., Stack A., Kabbaj M., Nestler E.J. Genome-wide analysis of chromatin regulation by cocaine reveals a role for sirtuins. Neuron 2009, 62:335-348.
22. Gao J., Wang W.Y., Mao Y.W., Graff J., Guan J.S., Pan L., Mak G., Kim D., Su S.C., Tsai L.H. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 2010, 466:1105-1109.
23. Liu G.S., Zhang Z.S., Yang B., He W. Resveratrol attenuates oxidative damage and ameliorates cognitive impairment in the brain of senescence-accelerated mice. Life Sci. 2012, 91:872-877.
24. Cristofol R., Porquet D., Corpas R., Coto-Montes A., Serret J., Camins A., Pallas M., Sanfeliu C. Neurons from senescence-accelerated SAMP8 mice are protected against frailty by the sirtuin 1 promoting agents melatonin and resveratrol. J. Pineal Res. 2012, 52:271-281.
25. Ho D.J., Calingasan N.Y., Wille E., Dumont M., Beal M.F. Resveratrol protects against peripheral deficits in a mouse model of Huntington's disease. Exp. Neurol. 2010, 225:74-84.
26. Rajasethupathy P., Fiumara F., Sheridan R., Betel D., Puthanveettil S.V., Russo J.J., Sander C., Tuschl T., Kandel E. Characterization of small RNAs in Aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron 2009, 63:803-817.
27. Preethi J., Singh H.K., Charles P.D., Emmanuvel Rajan K. Participation of microRNA 124-CREB pathway: a parallel memory enhancing mechanism of standardised extract of Bacopa monniera (BESEB CDRI-08). Neurochem. Res. 2012, 37:2167-2177.
28. Han Y.S., Zheng W.H., Bastianetto S., Chabot J.G., Quirion R. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br. J. Pharmacol. 2004, 141:997-1005.
29. Marambaud P., Zhao H., Davies P. Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J. Biol. Chem. 2005, 280:37377-37382.
30. Savaskan E., Olivieri G., Meier F., Seifritz E., Wirz-Justice A., Muller-Spahn F. Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. Gerontology 2003, 49:380-383.
31. Wang Q., Yu S., Simonyi A., Rottinghaus G., Sun G.Y., Sun A.Y. Resveratrol protects against neurotoxicity induced by kainic acid. Neurochem. Res. 2004, 29:2105-2112.
32. Gacar N., Mutlu O., Utkan T., Komsuoglu Celikyurt I., Gocmez S.S., Ulak G. Beneficial effects of resveratrol on scopolamine but not mecamylamine induced memory impairment in the passive avoidance and Morris water maze tests in rats. Pharmacol .Biochem. Behav. 2011, 99:316-323.
33. Sahu S.S., Madhyastha S., Rao G.M. Neuroprotective effect of resveratrol against prenatal stress induced cognitive impairment and possible involvement of Na(+), K(+)-ATPase activity. Pharmacol. Biochem. Behav. 2013, 103:520-525.
34. Borra M.T., Smith B.C., Denu J.M. Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 2005, 280:17187-17195.
35. Kaeberlein M., McDonagh T., Heltweg B., Hixon J., Westman E.A., Caldwell S.D., Napper A., Curtis R., DiStefano P.S., Fields S., Bedalov A., Kennedy B.K. Substrate-specific activation of sirtuins by resveratrol. J. Biol. Chem. 2005, 280:17038-17045.
36. Lagos-Quintana M., Rauhut R., Yalcin A., Meyer J., Lendeckel W., Tuschl T. Identification of tissue-specific microRNAs from mouse. Curr. Biol. 2002, 12:735-739.
37. Schratt G.M., Tuebing F., Nigh E.A., Kane C.G., Sabatini M.E., Kiebler M., Greenberg M.E. A brain-specific microRNA regulates dendritic spine development. Nature 2006, 439:283-289.
38. Walle T. Bioavailability of resveratrol. Ann. NY Acad. Sci. 2011, 1215:9-15.
39. Cottart C.H., Nivet-Antoine V., Laguillier-Morizot C., Beaudeux J.L. Resveratrol bioavailability and toxicity in humans. Mol. Nutr. Food Res. 2010, 54:7-16.
40. Dudley J., Das S., Mukherjee S., Das D.K. Resveratrol, a unique phytoalexin present in red wine, delivers either survival signal or death signal to the ischemic myocardium depending on dose. J. Nutr. Biochem. 2009, 20:443-452.
41. de la Lastra C.A., Villegas I. Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications. Biochem. Soc. Trans. 2007, 35:1156-1160.